Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GRPH Graphite Bio (GRPH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Graphite Bio Stock (NASDAQ:GRPH) 30 days 90 days 365 days Advanced Chart Ad Weiss RatingsProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Get Graphite Bio alerts:Sign Up Key Stats Today's Range$3.05▼$3.2350-Day Range$3.18▼$26.1152-Week Range$2.01▼$4.26Volume328,300 shsAverage Volume282,405 shsMarket Capitalization$185.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGraphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.Read More… Protect Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Receive GRPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Graphite Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address GRPH Stock News HeadlinesCarbonScape plans to build biographite plant in FinlandSeptember 18, 2024 | finance.yahoo.comVersant Vantage II, L.P.'s Net WorthMay 16, 2024 | benzinga.com24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast world of passive crypto income, where you set up a dependable income stream that works for you, whether you're at your computer or living your life.October 29, 2024 | Crypto Swap Profits (Ad)LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate ProgressMarch 21, 2024 | finance.yahoo.comGRPH Mar 2024 5.000 putMarch 15, 2024 | finance.yahoo.comVERI, STI and VERB among mid-day moversMarch 15, 2024 | seekingalpha.comGRPH Mar 2024 7.500 callMarch 15, 2024 | finance.yahoo.comGraphite Bio, Inc. (GRPH)March 14, 2024 | finance.yahoo.comSee More Headlines GRPH Stock Analysis - Frequently Asked Questions How were Graphite Bio's earnings last quarter? Graphite Bio, Inc. (NASDAQ:GRPH) released its quarterly earnings results on Monday, March, 20th. The company reported ($3.08) earnings per share for the quarter, topping the consensus estimate of ($3.43) by $0.35. When did Graphite Bio's stock split? Graphite Bio shares reverse split on the morning of Friday, March 22nd 2024. The 1-7 reverse split was announced on Friday, March 22nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. When did Graphite Bio IPO? Graphite Bio (GRPH) raised $224 million in an initial public offering (IPO) on Friday, June 25th 2021. The company issued 14,000,000 shares at a price of $15.00-$17.00 per share. What other stocks do shareholders of Graphite Bio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Graphite Bio investors own include Palantir Technologies (PLTR), Taiwan Semiconductor Manufacturing (TSM), Advanced Micro Devices (AMD), Carnival Co. & (CCL), Micron Technology (MU), PayPal (PYPL) and SoFi Technologies (SOFI). Company Calendar Last Earnings3/20/2023Today10/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:GRPH CUSIPN/A CIK1815776 Webwww.graphitebio.com Phone650-484-0886FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-124,650,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-33.12% Return on Assets-27.96% Debt Debt-to-Equity RatioN/A Current Ratio39.20 Quick Ratio39.20 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.15 per share Price / Book1.01Miscellaneous Outstanding Shares58,240,000Free Float35,874,000Market Cap$185.20 million OptionableNot Optionable Beta0.20 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:GRPH) was last updated on 10/29/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graphite Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Graphite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.